A true breakthrough: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity Science , a popular journal published by the American Association for the Advancement of Science (AAAS), has announced that ongoing research into the benefits of GLP-1 agonists such as semaglutide is its 2023 Breakthrough of the Year
Hyperglycemia and hyperlipidemia with kidney or liver transplantation: A review
Your metabolism, insulin sensitivity, and hormone levels all play a role
This support is important for long-term weight management
Antioxidant & Immune Protection Selenium & Zinc: Strengthen the immune system, protect cells from oxidative stress, and support reproductive health in both men and women
Syra Hanif , a board-certified primary care physician at Manhattan Medical Arts , breaks down the common and uncommon side effects of Zepbound, how long they last, and when to call a healthcare provider